News
Introducing Additional Column Volumes for CIMmultus® Line
In response to valuable client feedback and growing demand, we are excited to announce additional column volumes of our CIMmultus® line. The new column volumes are designed as a parallel...
Read moreIntroducing Leasing Options for Alkalizator and PATfix
Cost-effective leasing options for Alkalizator and PATfix, enabling immediate access to cutting-edge bioprocessing technology without CAPEX.
Read moreFrom Turbulence to Triumph: Sartorius BIA Separations' Rise as a Global Biotech Leader
Learn how Sartorius BIA Separations became a global biotech leader in purification technologies, impacting patient safety and advancing the sector.
Read moreSartorius BIA Separations Announces Major Price Reduction on 1 mL Columns
In a move to enhance accessibility and support innovation, Sartorius BIA Separations is pleased to announce a 45% price reduction on our 1 mL columns across all chemistries, effective September...
Read moreBIA Separations Introduces Cornerstone AAV Process Development Service to Accelerate Gene Therapy Production
CORNERSTONE program integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of Gene Therapy Medicinal Products (GTMPs). Portfolio includes novel CIMasphere™ technology for higher yielding...
Read moreTransforming Plasma-Derived Medicinal Product Manufacturing With Monoliths (A Case Study With NBI)
National Bioproducts Institute NPC (NBI), a South African pharmaceutical company, faced the challenge of modernizing its manufacturing processes to produce a cost-effective 20% immunoglobulin (IgG) solution for subcutaneous administration (SCIG)....
Read moreSartorius BIA Separations v okviru InCastre učencem predstavili karierni izziv
Ajdovščina, 20. september 2024 – V podjetju Sartorius BIA Separations d. o. o. so v okviru letošnje InCastre učencem 8. razredov osnovne šole predstavili izziv, kako pustiti odprt prostor za...
Read moreEkipi Sartorius BIA Separations zlato priznanje GZS za inovacijo Alkalizator
Sartorius BIA Separations d.o.o. in IntBas d.o.o. sta kot prijaviteljici prejeli zlato nacionalno priznanje Gospodarske zbornice Slovenije za inovacijo Alkalizator. Alkalizator, instrument za kontinuirno celično lizo, je plod izključno slovenskega...
Read moreBiomay and BIA Separations Collaborate on Production and Purification of Large DNA Plasmids
Collaboration enables high yield, high purity supercoiled plasmid DNA manufacture for therapeutic application BIA Separations, a leading biochromatography development and manufacturing company, and Biomay, a contact manufacturer of cGMP biopharmaceuticals,...
Read moreIntroducing CIMac QA HR: Highest AAV Empty-Full Reproducibility in AAV Analytics
We are excited to announce the launch of CIMac QA HR, the latest addition to our CIMac family of analytical columns, specifically developed for highly reproducible AAV empty-full HPLC analysis....
Read moreRegresi, nagrade in bonusi: V ajdovskem podjetju med najvišjimi nagradami za svoje zaposlene
Pred dopusti izplačilo regresa v višini 2.279,52 EUR na zaposlenega. V podjetju Sartorius BIA Separations se zavedajo, da uspešnost podjetja temelji na znanju in zavzetosti zaposlenih. Nagrajevanje tudi motivatorski element....
Read moreDownstream AAV Production: A Targeted Approach to Improve Empty | Full Capsid Separation (a Case Study with Pharmaron)
One of the greatest challenges for AAV production is the ability to purify full (product genome containing) from empty (non-product containing) viral capsids. Separation of empty from full capsids is...
Read moreZlato priznanje za inovacijo podjetju Sartorius BIA Separations za Alkalizator
Sartorius BIA Separations d.o.o. in IntBas d.o.o. sta kot prijaviteljici prejeli zlato priznanje Severno Primorske gospodarske zbornice za inovacijo Alkalizator. Alkalizator, instrument za kontinuirno celično lizo, je plod izključno slovenskega...
Read moreSelitev v nove dodatne laboratorijske prostore: Priložnost za nove preboje na področju zdravljenja raka in genskih terapij
Z biotehnologijo v mali vipavski dolini posegamo v sam vrh znanstvenega razvoja, raziskav, analitike in prečiščevanja spojin za zdravila za zdravljenje raka, genske terapije ter izdelkov s filtri za prečiščevanje...
Read moreBIA Separations Introduces PrimaS Multi-mode Ligand Bioprocessing Technology to Facilitate Development of Advanced Therapeutics
Novel platform initially focussed on high-resolution industrial scale processing of therapeutic mRNA Ajdovščina, Slovenia, 16 June 2020: BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of...
Read moreBiofair: Med študenti na kariernem dogodku največ pozornosti zdravilom za zdravljenje raka
Naši strokovnjaki in znanstveniki so na največjem kariernem dogodku za študente s področja ved o življenju Biofair, ki je potekal 14. in 15. maj 2024 na Fakulteti za kemijo in...
Read moreCIMmultus™ C4 HLD Advanced Composite Column cGMP
Recovery of pDIKE2 Plasmid for Hepatitis C Vaccine Using CIMmultus™ C4 HLD Advanced Composite Column cGMP pIDKE2 plasmid is the main component of the CIGB's candidate vaccine against Hepatitis C...
Read moreBIA Separations – Story of Success in Trend Wirtschaft Magazine
Sartorius BIA Separations d.o.o. Mirce 21, 5270 Ajdovscina Slovenia Phone: 386 (0) 59 699 500 Fax: +386 (0) 59 699 599 E-mail: sales@biaseparations.com
Read moreBIA Separations Expands with New Upstream Processing Facility
Investment in new lab will support integrated optimisation of upstream and downstream process development Provides single source of expertise for scaled production of complex biologics for gene therapy and vaccines...
Read moreBIA Separations Recognized as one of the 10 Best Biotech & Pharma Companies to Keep an Eye on in 2019
BIA Separations is always one step ahead of its competitors with its genuinely unique and extraordinary fractionation performance. No other chromatography media format can match monoliths for capacity, speed, resolution,...
Read moreBIA Separations Selected for Manufacturing Process Development Support for Gene Therapy Pipeline
BIA Separations will provide expertise in next generation biomolecule purification processes and long-term supply of CIMmultus™ monolithic columns Initial focus on the manufacture of Zolgensma®, a gene therapy for pediatric...
Read moreBIA Separations Announced as a Finalist in Category European CRO of the Year
The annual, European Lifestars Awards bring together hundreds of European life science leaders, investors, partners and deal makers, and is a celebration of the success stories, breakthroughs, transactions and transformational...
Read moreBIA Separations Signs two new Distribution Agreements Extending Coverage in Asia Pacific
• GeneX India Biosciences takes over sole distribution activities in India • IT Technologies will operate in Singapore and Malaysia Ajdovščina, Slovenia, 08 July 2020: BIA Separations, a leading bio-chromatography development...
Read moreGold Award for the Champions of Slovenian Science and High Technology
At today's award ceremony for the best innovations of the Northern Primorska region, BIA Separations received the gold award for innovation in the development of the purification process of the...
Read moreBIA Separations Gained Creating for Centuries Award
BIA Separations received ‘The Creating for Centuries Award’ for development of ideas, innovations and investments in Entrepreneurship in Central and SE Europe for 2019. International Economy Forum 'Perspective' based in...
Read moreIntroduction of speCIMen
Accelerated adoption of advanced therapy medicinal products (ATMP) is leading to the wider use of new therapeutic modalities such as viruses, DNA, RNA. Manufacturers must now contend with an increased...
Read moreBIA Separations (Sartorius) is Now Part of the New EIC Pathfinder Project Yscript
Project title: Yeast cell factory for mRNA bioproduction Project duration: April 2022 - March 2025 Partners: CNRS, INRAE, UAVR, UBI, TRON gGmbH, EURICE, IBCH PAS, BIASEP On April 1, 2022, BIA Separations (Sartorius)...
Read moreNew Achievement: The Best Performing Company in Slovenia
Sartorius BIA Separations has for the first time been considered as a large company in Slovenian industrial (business) space. Each year a magazine Finance Manager ranks the best performing companies...
Read moreTeknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
An AAV Chromatography Platform Plus Optimized Custom Buffer Formulations Yields a State-of-the-Art Offering for Increased AAV Recovery Hollister, Calif., March 15, 2023 (Globe Newswire) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq:...
Read moreBIA Separations at the Diplomatic Regatta 2013
On Saturday, September 14, a great event took place in the beautiful coastal city of Izola, Slovenia. The traditional 11th Diplomatic Regatta gathers sailors, diplomats, politicians and businessman and offers...
Read moreThe Lucky Winner of the Free Participation Fee for the Monolith Summer School and Symposium 2014 is Dr. Carl Ross!
The satisfaction of customers is of utmost importance to the BIA Separations leadership and staff. This is why we've decided to check with them wheather they are satisfied with the...
Read moreBIA Separations Attends the 4th Annual Vaccine Congress
Last week BIA Separations attended an IMAPAC event, the 4th Annual Vaccine Congress which took place in Hyderabad, India from March 4 to March 6. At the event the latest...
Read moreSocial Responsibility
Instead of sending Christmas Cards BIA Separations has decided that in this times of crisis, best wishes and regards to business partners and friends can be expressed electronically as well....
Read morePress
Instead of sending Christmas Cards BIA Separations has decided that in this times of crisis, best wishes and regards to business partners and friends can be expressed electronically as well....
Read moreNew Product: CIMac™ Adeno Analytical Column
The new CIMac™ Adeno-0.1 Analytical Column is a column perfect for process analytical technology (PAT). PAT is a system for analysis and control of manufacturing processes that measures critical quality...
Read moreSDK and BIA Separations Expanding Their Cooperation
Villach, Austria, July 29, 2014 BIA Separations GmbH and its co-owner and trusted business partner Showa Denko K. K. decided to facilitate the access and secure the long term supply...
Read moreLet's Meet
Don't miss the opportunity to meet one of our experts in field of liquid chromatography again. It doesn't matter if you already know monoliths and are working with them or...
Read more3rd Workshop: The new ParadIgM – IgM from Bench to Clinic
Dear colleagues With great pleasure we received lots of positive feedbacks on the first and second workshop on IgM, held in Frankfurt 2011 and 2013, showing the increasing interest in...
Read moreOffices Closed
Dear Sir or Madam, from the 23rd of December until the end of the year 2014 BIA Separations will be on holidays. Our offices will re-open on the 5th of...
Read more1000 Successful Stories, 1000 Satisfied Customers, 1000 FINISHED PROJECTS
Our CRO (Contract research) department has successfully finished the 1000th project. Congratulations to the Head of CRO department Mira Kordiš-Krapež and her team! BIA Separations´ Contract Research Service is an...
Read moreSartorius BIA Separations and Arnav Biotech Enter in Collaboration to Develop a mRNA Synthesis and Purification Platform, Supported with PATfix In-Process Analytical Solution
Atlanta, Georgia and Ajdovscina, Slovenia, 2 February 2023 Project combines Sartorius BIA Separations’ platforms for purification and analytics with Arnav’s innovative mRNA pipeline. The collaboration will leverage the companies’ track...
Read moreSartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology for Large-Scale Exosome Production
Melbourne, Australia and Ajdovščina, Slovenia, 22 November 2022 • Partnership will address technical challenges of large-scale, high-efficiency purification of therapeutic exosomes for non-viral drug delivery • Programme combines novel technologies...
Read moreThank you for Attending Monolith Summer Symposium!
Be sure to mark your calendars for our next MSS, planned for June 3-7, 2024, as Hybrid event. We are more than thankful that you attended our event. We are...
Read moreBioNet and Sartorius' Company BIA Separations Collaborate on Production Process Development of mRNA Vaccines
Represents commitment to global efforts against COVID-19 with optimized mRNA production using proprietary chromatographic columns and process Manufacturing process successful in production of COVID-19 mRNA Ajdovščina, Slovenia & Bangkok, Thailand,...
Read moreBIA Separations to Supply Columns for mRNA Purification
BIA Separations has been able to respond quickly to the Healthcare field’s urgent need to improve manufacturing technology for mRNA. Our scientists have worked closely with Arcturus’ excellent team to...
Read moreBIA Separations Welcomes a new Specialized Expert to the Team
We are happy to announce that BIA Separations, now part of Sartorius group, welcomed a new team member: Rok Sekirnik, PhD was appointed as Head of Process Development mRNA/pDNA at...
Read moreVivaZome and BIA Separations to Collaborate on Downstream Technology for Exosome Purification
21 December 2020; Melbourne Australia and Ajdovščina, Slovenia: VivaZome Therapeutics Pty Ltd (“VivaZome”) and BIA Separations (“BIA”) – a part of the life science group Sartorius – today announced that they...
Read moreBIA Separations Receives Highest National Award for Innovations
We have received the highest national award for innovative achievements: a gold innovation award given by the Slovenian Chamber of Commerce and Industry. Our winning achievement: development of the Zolgensma...
Read morePurification Specialist BIA Separations to Become Part of Sartorius
Combination of businesses will create a premium portfolio for advanced therapies. BIA Separations will be Sartorius’ center of excellence for purification of cell and gene therapeutics. The life science company...
Read morePurification of Drugs is Key to Their Safety and Success
Ajdovščina, 24 January - The Ajdovščina-based company BIA Separations is a world leader in the development of purification processes for biologics, in particular for gene therapy. According to Chief Scientific...
Read moreBIA Separations Introduces CORNERSTONE Exosome Process Development Solution to Enable Industrial Scale Manufacture of Therapeutic Exosomes
Platform combines proprietary new technologies for high yield purification of exosomes: Kryptonase™ and CIMmultus™ EV monolithic column. Coordinated purification process development service integrates BIA Separations’ expertise to accelerate progress to...
Read morePlatform Purification of Clinical-Quality Bacteriophages Published in BioProcess Internationl's Industry Yearbook
Antibiotics are unable to keep pace with infectious diseases, and the use of bacteriophages is a timely solution to that problem. But implementation of bacteriophages involves overcoming some challenges. Broad-spectrum...
Read moreBIA Separations Finalist in 2019 Zlata Nit Competition for the Best Slovenian Employer
The selection of the best employers is a unique media project carried out by newspaper Dnevnik. The purpose of the competition is to select and reward the best employees of...
Read moreBIA Separations Recognized as one of the Big Players
Kalorama Information, a leading publisher of market research in healthcare area, published Market research: 2018 Downstream Bioprocessing Markets (Chromatography Columns and Resins Membrane Adsorbers Filtration Systems Sensors), where BIA Separations...
Read moreJoin us on BIA's Seminar in Shanghai, China
BIA will organize a seminar about CIM monoliths for purification and in-process control of macromolecules with an emphasis on gene therapy and vaccines. Date: 2018/9/4; 8:30 am - 12 pm....
Read moreBIA Separations Partners With RBPS Technology to Provide Large Scale Minicircle DNA Vector Production
Collaboration supports clinical-scale production of high purity Minicircle DNA for viral and non-viral gene transfer. Ajdovščina, Slovenia and Vienna, Austria, 21 March 2018: BIA Separations, a leading biochromatography development and manufacturing...
Read moreBIA Separations and Nuvonis Technologies Partner to Support Vaccine and Gene Therapy Production
Agreement combines strengths in upstream and downstream process development. BIA Separations, a leading biochromatography development and manufacturing company, and Nuvonis Technologies (Nuvonis), a biotech company providing innovative production cell banks,...
Read moreBIA Separations Appoints Pete Gagnon as Chief Scientific Officer
BIA Separations (BIA), a leading biochromatography development and manufacturing company, today announced it has appointed Pete Gagnon as Chief Scientific Officer. In his new role, he will drive the company’s...
Read moreBIA Separation is looking for New Distributors
Looking for new products to present in your market? Can you help us enter a new market? Are you familiar with our products and would like to offer them in...
Read moreNew Distributors Appointed for Sweden and Norway
BIA Separations has expanded its network and appointed Teknolab Sorbent ABT as new distributor for Sweden and Teknolab AS for Norway. We look forward for a long and successful partnership....
Read moreNew Distributor Appointed for Thailand – Applied Chemical and Instrument Co.,Ltd.
BIA Separations has expanded its network and appointed Applied Chemical and Instrument Co.,Ltd. as our new distributor for Thailand. The company has been founded on 2005 as Applies Chemical Ltd....
Read moreNew Distributor Appointed for India
BIA Separations has expanded its network and appointed Nilsan Nishotech Systems Pvt Ltd. as our new distributor for India. Nilsan Nishotech Systems is a well established company with 25 years of...
Read moreBIA Separations Slovenia Raises EUR 1.5 Million from META Ingenium
BIA Separations Slovenia has raised 1.5 EUR from META Ingenium managed by Luigi Amati and Nina Mazgan in order to expand the business to food industry and strengthen its balance...
Read moreDon't Miss BIA Separations' Webinar
Date: Thursday 17th September 2015 Time: 3pm London/10am New York You will lear how to: move from process parameter to direct critical quality attribute monitoring, identify the right harvetsing time point in recombinant...
Read moreBIA Separations Hosts Students From Naples
From July 13 to July 17, nine students from I.S.I.S. GUIDO TASSINAKI, Naples visited BIA Separations as part of their one-month stay in Slovenia. The students who participated were selected...
Read moreDistributor Meeting
From July 1st to July 3rd, the new members of the BIA Separations' worldwide distribution visited BIA Separations facility in Ajdovščina for the distributor meeting. Delegates participated in an intensive...
Read moreBIA Separations Hosts Visitors From the Moscow School of Economics
Fifteen students from Moscow School of Economics (M. V. Lomonosov MSU) visited BIA Separations R&D laboratories and manufacturing facilities on 16th June 2015. The students were shown the R&D facilities...
Read moreBIA Separations Appoints Hichrom as Distributor
Following the continuous expansion of BIA Separations' operations in the UK, the company announced today that it is expanding its distribution network in the UK through collaboration with Hichrom Limited....
Read moreJoin our Head of Marketing @ Single Use Days
Join our Head of Marketing, Lidija Urbas, PhD in Boston, MA, USA. She will give a lecture on BIA Separations single use technology. See you there! To register send an...
Read moreBIA Separations Expanding Its Distribution Network in India
BIA Separations is proud to announce the expansion of its distribution network in India through collaboration with Medi Analytika India Pvt. Ltd. Medi Analytika India Pvt. Ltd. is one of...
Read moreBIA Separations Expanding Its Distribution Network in China
BIA Separations is expanding its network in China with the appointment of Guangzhou Bairui Medicine (hereinafter as Bairui) as a BIA Separations distributor. Bairui is a GSP certified pharmaceutical company...
Read moreBIA Separations and Labena Start Long Term Partnership
BIA Separations, the world leading developer and manufacturer of CIM® (Convective Interaction Media) monolithic chromatographic columns and process development services strikes partnership with Labena d.o.o., one of the leading providers...
Read moreNew Distributor in Portugal
BIA Separations is proud to announce the expansion of its distribution network in Portugal through collaboration with Tecnocroma-Tecnicas Analiticas, Lda. Tecnocroma is the only company in Portugal exclusively dedicated to...
Read moreHappy Holidays
Dear Sir or Madam, from the 24th of December until the end of the year 2015 BIA Separations will be on holidays. Our offices will re-open on the 4th of January 2016....
Read moreBIA Separations in European Awards Competition
From today, you can register your vote for BIA Separations in the competition for the title of 'National Public Champion' in this year's EuropeanBusiness Awards, as the public vote opens for the first time. The...
Read more4th World Congress on Chromatography
Meet us at 4th World congress on Chromatography 07 - 09 August 2017 - Place: Holiday Inn Rome Aurelia | City: Rome, Italy Speaker: Romina Žabar Phd., Senior researcher at BIA...
Read moreMeet us at BioProcess International European Summit 2016
Meet us at BioProcess International European Summit 11 - 14 April 2016 - Place: Reed Messe Wien Congress Center | City: Vienna, Austria Visit us at our booth number #28. Invited...
Read more7th Monolith Summer School & Symposium, 27 May – 1 June 2016, Slovenia
Attend lectures by world class reserchers and monolith experts and participate in our cutting edge workshops 27 May – 1 June 2016, Place: Remisens Premium Hotel Metropol | City: Portoroz, Slovenia The...
Read morePATfinder™ – Free Lunch Seminar Series
In the week from June 20-27, please join us for a free lunch seminar on PATfinder™, our rapid, powerful, and highly flexible chromatography system designed for Process Analytical Technology (PAT)....
Read moreCell Therapy Manufacturing & Gene Therapy Congress
Connecting cell and gene therapy leaders to drive manufacturing and commercialisation through direct access to innovative discovery, product development and regulatory know-how. 29 November - 30 November 2016, Place: RAI,...
Read moreMSS 2018 – 8th Monolith Summer School & Symposium
The 8th MSS will be held from June 15th -20th 2018 in beautiful Portorož, coastal town of Slovenia. The tradition of the MSS will offer new opportunities to expand your...
Read moreCell Therapy Manufacturing & Gene Therapy Congress 2016
Meet us at Cell Therapy Manufacturing & Gene Therapy Congress 29 to 30 November 2016, Place: Rai Amsterdan City: Amsterdam, Netherlands. Speaker: Aleš Štrancar, BIA Separations CEO Session Cell, Gene...
Read more4th Fall ISBioTech Meeting 2016
Listen us at 4th Fall ISBioTech Meeting 12 December 2016, Place: 3001 Atlantic Ave, Virginia Beach, VA 23451, USA Speaker: Sebastijan Peljhan, PhD HPLC Fingerprinting Approach for Increased Speed and...
Read moreListen us at First Congress BioProcess Cuba 2017
23th February 2017, Place: Camaguey, Cuba Speaker: Sebastijan Peljhan, PhD HPLC Fingerprinting Approach for Increased Speed and Flexibility of PAT; Feb 23 More information: http://bpcuba2017.cigb.edu.cu/index.php/en/
Read more4th World Congress on Chromatography
Meet us at 4th World congress on Chromatography 07 - 09 August 2017 - Place: Holiday Inn Rome Aurelia | City: Rome, Italy Speaker: Romina Žabar Phd., Senior researcher at BIA...
Read morePhages 2017
Meet MSc. Tomas Kostelec, Technology & Busineess Development Manager at Phages. September 13-14, 2017. St Hilda's College, Oxford, UK. More information: http://lpmhealthcare.com/phages-2017/
Read moreXXV Anniversary Congress-ESGCT
Meet us at XXV Anniversary Congress- ESGCT. 17-20 October 2017 in Berlin, Germany at Berlin Congress Center. More information: https://www.esgct.eu/Congress.aspx
Read moreCell Therapy Manufacturing & Gene Therapy Congress in Amsterdam
Meet us at Cell Therapy Manufacturing & Gene Therapy Congress from 06 December 2017 to 07 December 2017 in Amsterdam, Netherlands. More information: https://lifesciences.knect365.com/celltherapy/
Read moreMeet us at CAR-TCR Summit Europe
The leading dedicated end-to-end summit focused on the global delivery of safe, effective and commercially successful CAR and TCR cell immunotherapies.The CAR-TCR Summit Europe brings you access to the leaders...
Read moreHydrogen Bond Chromatography – BIA Separations publication in BPI
A whole new tool for enhanced separation of proteins from virus particles and other very large biologics. BioProcess International™ is a well-known monthly, controlled-circulation magazine devoted to the development, scale-up,...
Read moreMonolithic Chromatography Enables Process Intensification of Virus Purification
Monoliths are unique from other forms of chromatography media for several reasons. Monolith architecture consists of highly interconnected convective channels that are distributed throughout the entire bed. The large channels...
Read moreTaming the Last Frontier: Harmonizing the Upstream-Downstream Interface
Pete Gagnon, Chief Scientific Officer of BIA Separations, has worked with most of the major international biopharma companies, dozens of start-ups and intermediate size companies, and nearly all of the...
Read moreUpon the visit of US Ambassador, BIA Separations announces production expansion to North America
The US Ambassador to Slovenia Lynda C. Blancard visited BIA Separations in Ajdovščina yesterday. She was introduced to the innovative technologies developed in Slovenia and to company's plans that include launching a...
Read moreBIA Separations and University of Zagreb Sign License Agreement to Commercialize Novel Elution Method for Virus and Viral Vector purification
Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy Ajdovščina, Slovenia and Zagreb, Croatia, 19 February 2020: BIA...
Read moreSartorius Creates a Premium Gene Therapy and Vaccine Portfolio With the Acquisition of BIA Separations
In November, Sartorius acquired BIA Separations—a company that develops and manufactures market-leading products for the purification and analysis of large biomolecules based in Slovenia. “BIA´s portfolio is highly complementary to...
Read moreA Time of Celebration, Expansion and a Richer Portfolio
This October Sartorius BIA Separations is celebrating the 25th anniversary, which we memorialized today with a special event. Among our distinguished guests were the mayor, representatives from the Slovenian government,...
Read moreThe Republic of Slovenia and the European Union Are Co-funding the Investment of a Solar Power Station From the Cohesion Fund
Sartorius BIA Separations, separation technologies, d.o.o., Mirce 21, 5270 Ajdovščina is successfully finalizing the construction of the Solar power station Bia Separations (SE BIA SEPARATIONS), located at Mirce 21. The...
Read more